TY - JOUR
T1 - Advances in novel drug delivery strategies for breast cancer therapy
AU - Dhankhar, Ritu
AU - Vyas, Suresh P.
AU - Jain, Arvind K.
AU - Arora, Sahil
AU - Rath, Goutam
AU - Goyal, Amit K.
N1 - Generated from Scopus record by KAUST IRTS on 2023-10-12
PY - 2010/10/1
Y1 - 2010/10/1
N2 - Breast cancer remains one of the world's most devastating diseases. However, better understanding of tumor biology and improved diagnostic devices could lead to improved therapeutic outcomes. Nanotechnology has the potential to revolutionize cancer diagnosis and therapy. Various nanocarriers have been introduced to improve the therapeutic efficacy of anticancer drugs, including liposomes, polymeric micelles, quantum dots, nanoparticles, and dendrimers. Recently, targeted drug delivery systems for anti-tumor drugs have demonstrated great potential to lower cytotoxicity and increase therapeutic effects. Various ligands/approaches have been explored for targeting breast cancer. This paper provides an overview of breast cancer, conventional therapy, potential of nanotechnology in management of breast cancer, and rational approaches for targeting breast cancer. © 2010 Informa Healthcare USA, Inc.
AB - Breast cancer remains one of the world's most devastating diseases. However, better understanding of tumor biology and improved diagnostic devices could lead to improved therapeutic outcomes. Nanotechnology has the potential to revolutionize cancer diagnosis and therapy. Various nanocarriers have been introduced to improve the therapeutic efficacy of anticancer drugs, including liposomes, polymeric micelles, quantum dots, nanoparticles, and dendrimers. Recently, targeted drug delivery systems for anti-tumor drugs have demonstrated great potential to lower cytotoxicity and increase therapeutic effects. Various ligands/approaches have been explored for targeting breast cancer. This paper provides an overview of breast cancer, conventional therapy, potential of nanotechnology in management of breast cancer, and rational approaches for targeting breast cancer. © 2010 Informa Healthcare USA, Inc.
UR - http://www.tandfonline.com/doi/full/10.3109/10731199.2010.494578
UR - http://www.scopus.com/inward/record.url?scp=77956590417&partnerID=8YFLogxK
U2 - 10.3109/10731199.2010.494578
DO - 10.3109/10731199.2010.494578
M3 - Article
SN - 1073-1199
VL - 38
SP - 230
EP - 249
JO - Artificial Cells, Blood Substitutes, and Biotechnology
JF - Artificial Cells, Blood Substitutes, and Biotechnology
IS - 5
ER -
